triazoles has been researched along with transferrin in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CAROLINE, L; KOZINN, PJ; SCHADE, AL; TASCHDJIAN, CL | 1 |
| Arion, VB; Eichinger, R; Groessl, M; Hartinger, CG; Jakupec, MA; Keppler, BK; Reisner, E; Semenova, O; Timerbaev, AR | 1 |
| Ozawa, K | 1 |
| Hershko, C | 1 |
| Adams, PC; Bonkovsky, HL; Brissot, P; Griffel, L; Gross, J; Lynch, N; Malfertheiner, P; McLaren, GD; Niederau, C; Phatak, P; Pietrangelo, A; Piperno, A; Powell, LW; Russo, MW; Stoelzel, U; Stremmel, W; Wurster, M; Zhang, Y | 1 |
| Fibach, E; Ganz, T; Ghoti, H; Gordana, O; Rachmilewitz, EA; Westerman, M | 1 |
| Evans, P; Harmatz, P; Kurio, G; Lal, A; Neumayr, L; Ng, V; Porter, J; Sweeters, N; Vichinsky, E | 1 |
| Bardou-Jacquet, E; Beaumont-Epinette, MP; Ben Ali, Z; Brissot, P; Jouanolle, AM; Loreal, O | 1 |
| Cappellini, MD; Chan, LL; El-Alfy, M; El-Ali, A; Giraudier, S; Han, J; Lai, Y; Porter, JB; Viprakasit, V | 1 |
| Choi, SE; Han, SJ; Jung, IR; Jung, JG; Kang, Y; Kim, DJ; Kim, HJ; Lee, KW; Lee, SA | 1 |
| Berckmans, P; Covaci, A; Hollanders, K; Maho, W; Peers, B; Remy, S; Verstraelen, S; Witters, H | 1 |
| Aryasomayajula, B; Degterev, A; Deshpande, PP; Hartner, WC; Kulkarni, A; Nagelli, SG; Pattni, BS; Thakur, G; Torchilin, VP | 1 |
| Benjamín-Rivera, JA; Delgado, Y; Loza-Rosas, SA; Munet-Colón, C; Negrón, LJ; Parks, TB; Rivero, KI; Tinoco, AD; Vázquez-Maldonado, AL; Vázquez-Salgado, AM | 1 |
| Baratta, MG | 1 |
2 review(s) available for triazoles and transferrin
| Article | Year |
|---|---|
[Pathogenesis of transfusional iron overload and iron chelation therapy].
Topics: Administration, Oral; Benzoates; Chelation Therapy; Deferasirox; Deferoxamine; Drug Design; Erythrocyte Transfusion; Humans; Iron; Iron Chelating Agents; Iron Overload; Practice Guidelines as Topic; Transferrin; Triazoles | 2009 |
Non-HFE hemochromatosis: pathophysiological and diagnostic aspects.
Topics: Alcohol Drinking; Benzoates; Biopsy; Cataract; Cation Transport Proteins; Decision Trees; Deferasirox; Diet; Gaucher Disease; Genetic Testing; Hemochromatosis; Hemochromatosis Protein; Hepcidins; Histocompatibility Antigens Class I; Humans; Inflammation; Iron; Iron Chelating Agents; Iron Metabolism Disorders; Iron Overload; Liver; Macrophage Activation Syndrome; Magnetic Resonance Imaging; Membrane Proteins; Metabolic Syndrome; Mutation; Phlebotomy; Receptors, Transferrin; Transferrin; Triazoles | 2014 |
3 trial(s) available for triazoles and transferrin
| Article | Year |
|---|---|
Increased serum hepcidin levels during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndrome.
Topics: Aged; Antimicrobial Cationic Peptides; Benzoates; Blood Transfusion; Deferasirox; Erythropoiesis; Female; Hepcidins; Humans; Iron Chelating Agents; Iron Overload; Male; Middle Aged; Myelodysplastic Syndromes; Oxidative Stress; Transferrin; Triazoles | 2011 |
Combined chelation therapy with deferasirox and deferoxamine in thalassemia.
Topics: Adolescent; Adult; Benzoates; Chelation Therapy; Child; Deferasirox; Deferoxamine; Drug Synergism; Female; Ferritins; Humans; Iron; Iron Chelating Agents; Iron Overload; Liver; Male; Myocardium; Pilot Projects; Thalassemia; Transferrin; Triazoles; Young Adult | 2013 |
Utility of labile plasma iron and transferrin saturation in addition to serum ferritin as iron overload markers in different underlying anemias before and after deferasirox treatment.
Topics: Anemia; Benzoates; Biomarkers; Deferasirox; Female; Ferritins; Follow-Up Studies; Humans; Iron; Iron Overload; Male; Transferrin; Triazoles | 2016 |
9 other study(ies) available for triazoles and transferrin
| Article | Year |
|---|---|
REVERSAL OF SERUM FUNGISTASIS BY ADDITION OF IRON.
Topics: Blood; Candida; Culture Media; Humans; Iron; Iron Isotopes; Peptones; Transferrin; Triazoles | 1964 |
Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and antiprolif
Topics: Albumins; Antineoplastic Agents; Cell Line, Tumor; Colorimetry; Crystallography, X-Ray; Dimethyl Sulfoxide; Drug Screening Assays, Antitumor; Drug Stability; Electrophoresis, Capillary; Humans; Hydrogen-Ion Concentration; Imidazoles; Organometallic Compounds; Oxidation-Reduction; Potentiometry; Protein Binding; Ruthenium; Ruthenium Compounds; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Transferrin; Triazoles; Water | 2007 |
Pathogenesis and management of iron toxicity in thalassemia.
Topics: Benzoates; Deferasirox; Deferiprone; Deferoxamine; Homeostasis; Humans; Iron; Iron Chelating Agents; Iron Overload; Models, Molecular; Pyridones; Reactive Oxygen Species; Thalassemia; Transferrin; Transfusion Reaction; Triazoles | 2010 |
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis.
Topics: Adult; Aged; Amino Acid Substitution; Benzoates; Creatinine; Deferasirox; Dose-Response Relationship, Drug; Female; Ferritins; Hemochromatosis; Homozygote; Humans; Iron Chelating Agents; Iron Overload; Male; Middle Aged; Phlebotomy; Safety; Transferrin; Triazoles | 2010 |
Involvement of iron depletion in palmitate-induced lipotoxicity of beta cells.
Topics: Animals; Apoferritins; Benzoates; Cell Death; Cell Line, Tumor; Chlorides; Deferasirox; Deferoxamine; eIF-2 Kinase; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Ferric Compounds; Ferrous Compounds; Gene Expression Regulation; Humans; Insulin-Secreting Cells; Iron Chelating Agents; Iron Deficiencies; JNK Mitogen-Activated Protein Kinases; Palmitic Acid; Rats; Receptors, Transferrin; Signal Transduction; Transcription Factor CHOP; Transferrin; Triazoles | 2015 |
Phenotypic and biomarker evaluation of zebrafish larvae as an alternative model to predict mammalian hepatotoxicity.
Topics: Acetaminophen; Amiodarone; Animals; Apoptosis; Aryl Hydrocarbon Hydroxylases; Ceruloplasmin; Coumarins; Female; Gene Expression Regulation; Genetic Markers; Genome-Wide Association Study; Humans; In Situ Hybridization; Larva; Liver; Male; Methapyrilene; Nitriles; Oxidoreductases, N-Demethylating; Phenotype; Toxicity Tests; Transferrin; Triazoles; Zebrafish; Zebrafish Proteins | 2016 |
Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model.
Topics: Apoptosis; Cell Line, Tumor; Chlorophenols; Drug Delivery Systems; Female; Humans; Liposomes; Micelles; Ovarian Neoplasms; Prodrugs; Transferrin; Triazoles; Tumor Cells, Cultured | 2016 |
Expanding the Therapeutic Potential of the Iron Chelator Deferasirox in the Development of Aqueous Stable Ti(IV) Anticancer Complexes.
Topics: Antineoplastic Agents; Apoptosis; Benzoates; Cell Line, Tumor; Coordination Complexes; Deferasirox; Drug Design; Drug Stability; Humans; Iron; Iron Chelating Agents; Ligands; Models, Chemical; Molecular Structure; Serum Albumin; Titanium; Transferrin; Triazoles | 2017 |
Getting to the brain.
Topics: Animals; Antineoplastic Agents; Azepines; Blood-Brain Barrier; Brain; Brain Neoplasms; Drug Carriers; Drug Delivery Systems; Glioblastoma; Humans; Mice; Nanomedicine; Polyethylene Glycols; Temozolomide; Transferrin; Triazoles | 2018 |